John Morgan, MD
Neurology · Augusta, GANPI 1023127024
Payments from drug & device makers
Across 1,066 payments — averaging $1227.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amneal Pharmaceuticals LLC$275K
- UCB SA$200K
- AbbVie$191K
- Kyowa Kirin, Inc.$184K
- Lilly USA, LLC$98K
- Sunovion Pharmaceuticals Inc.$74K
- plus $287K from 43 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,308,805 in reported general payments places this provider in the 95th percentile of 506 neurology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Augusta
- Alexis ShaeferAugusta$279K
- Askiel BrunoAugusta$275K
- Jerry PruittAugusta$121K
- Bryan HoAugusta$97K
- Debra Moore-HillAugusta$88K
- Kapil SethiAugusta$55K
- Jonathan LissColumbus$25M
- Marshall NashDecatur$13.6M
- James LahAtlanta$6.8M
- Jonathan GlassAtlanta$5.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.